Share Prices & Company Research

Stockbroking

Avacta Group

Current Price 26.85p Bid 26.50p Ask 27.00p Change 0.00%
Last Updated: 19/07/2019 20:14. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Avacta Group plc's (formerly Readybuy plc) principal focus is on its proprietary Affimer technology which is a novel engineered alternative to antibodies that has wide application in Life Sciences for diagnostics, therapeutics and general research and development. Antibodies dominate markets worth in excess of $100bn despite their shortcomings. Affimer technology has been designed to address many of these negative performance issues, principally; the time taken to generate new antibodies, the reliance on an animal's immune response, poor specificity in many cases, and batch to batch variability. Affimer technology is based on a small protein that can be quickly generated to bind with high specificity and affinity to a wide range of protein targets. Avacta has a pre-clinical biotech development programme with an in-house focus on immuno-oncology as well as partnered development programmes. Avacta is commercialising non-therapeutic Affimer reagents through licensing to developers of life sciences research tools and diagnostics.

Financial Highlights Year Ended 31/07/2018

Turnover
£2.76m
Operating Profit
£-10.43m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-1.98

Key Personnel

Prof David Alastair Maclaughlin Smith
Chief Executive Officer
Tony Peter Gardiner
Chief Financial Officer
Dr Eliot Richard Forster
Non-Executive Chairman
Dr Samuel Cameron Williams
Non-Executive Director
Dr Michael John Owen
Non-Executive Director
Dr Trevor John Nicholls
Non-Executive Director

Stock Details

EPIC
AVCT
ISIN
GB00BYYW9G87
Shares in Issue
116,158,123
Market cap
£31.07m
Sector

Analyst Views (1)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
100.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
26.75p
Bid Price
26.50p
Ask Price
27.00p
Volume
276125
Change Today
0.00p
% Change Today
0.00%
Open
26.90p
Previous Close
26.75p
Intraday High
27.00p
Intraday Low
26.51p
52 Week High
50.50p
52 Week Low
21.20p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Avacta Group Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Jul 2018
31 Jul 2017
Tangible Assets
3.1
3.5
Intangible Assets & Goodwill
12.2
12.3
Investments & Other Non-Current Assets
0.0
0.0
Total Non-Current Assets
15.3
15.8
Inventory
0.2
0.2
Trade & Receivables
1.3
1.3
Cash & Receivables
5.2
9.2
Other Current Assets & Assets Held for Resale
1.5
5.2
Total Assets
23.5
31.6

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Jul 2018
31 Jul 2017
Short Term Liabilities
2.0
1.7
Long Term Liabilities
0.0
0.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
2.0
1.7

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Jul 2018
31 Jul 2017
Net Assets
21.4
29.9

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Jul 2018
31 Jul 2017
Share Capital
7.0
6.9
Minority Interests
0.0
0.0
Retained Earnings
16.3
24.8
Share Premium Account
0.8
0.6
Other Equity
-2.6
-2.5
Total Equity
21.4
29.9

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Jul 2018
31 Jul 2017
Cashflow from Operating Activities
-5.5
-4.2
Cashflow Before Financing
-4.0
-0.4
Increase / Decrease in Cash
-4.0
-0.4

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Jul 2018
31 Jul 2017
Turnover
2.8
2.7
Cost of Sales
0.9
0.9
Gross Profit
1.9
1.8
Operating Profit
-10.4
-8.0
Pre-Tax Profit
-10.4
-7.9
Profit / Loss for the Year
-8.8
-6.4
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.